Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder (vol 159, pg 255, 2002)

被引：0
|
作者：
Volavka
机构：
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 2002年 / 159卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：2132 / 2132
页数：1
相关论文
共 50 条
  • [31] Treatment of behavioural emergencies with olanzapine in patients with schizophrenia, schizoaffective or bipolar I disorder
    Huber, C. G.
    Lambert, M.
    Naber, D.
    Schacht, A.
    Wagner, T. T.
    Schimmelmann, B. G.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 433 - 433
  • [32] The influences of risperidone and clozapine on body weight and glucose level in patients with chronic schizophrenia - comparison with haloperidol
    Lee, JN
    Yang, BH
    Nam, CW
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S457 - S458
  • [33] Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients
    Barak, Y
    Shamir, E
    Zemishlani, H
    Mirecki, I
    Toren, P
    Weizman, R
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (06): : 1199 - 1202
  • [34] Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
    Gao, Keming
    Mackle, Mary
    Cazorla, Pilar
    Zhao, Jun
    Szegedi, Armin
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1145 - 1157
  • [35] Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy (vol 36, pg 1289, 2011)
    Friedman, Joseph I.
    Lindenmayer, Jean-Pierre
    Alcantara, Frances
    Bowler, Stephanie
    Parak, Mohan
    White, Leonard
    Iskander, Adel
    Parrella, Michael
    Adler, David N.
    Tsopelas, Nicholas D.
    Tsai, Wei-Yann
    Novakovick, Vladan
    Harvey, Philip D.
    Davis, Kenneth L.
    Kaushik, Saurabh
    [J]. NEUROPSYCHOPHARMACOLOGY, 2011, 36 (06) : 1317 - 1317
  • [36] Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy (vol 36, pg 1289, 2011)
    Friedman, Joseph I.
    Lindenmayer, Jean-Pierre
    Alcantara, Frances
    Bowler, Stephanie
    Parak, Mohan
    White, Leonard
    Iskander, Adel
    Parrella, Michael
    Adler, David N.
    Tsopelas, Nicholas D.
    Tsai, Wei-Yann
    Novakovick, Vladan
    Harvey, Philip D.
    Davis, Kenneth L.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2011, 36 (10) : 2150 - 2150
  • [37] Improvement of comorbid depression with olanzapine versus ziprasidone treatment in patients with schizophrenia or schizoaffective disorder
    Kinon, BJ
    Lipkovich, I
    Edwards, SE
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 491 - 491
  • [38] Improvement of comorbid depression with olanzapine versus ziprasidone treatment in patients with schizophrenia or schizoaffective disorder
    Kinon, BJ
    Lipkovich, I
    Edwards, SE
    Hill, AL
    Tollefson, GD
    [J]. BIOLOGICAL PSYCHIATRY, 2004, 55 : 185S - 186S
  • [39] Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder
    Lambert, M.
    Huber, C. G.
    Naber, D.
    Schacht, A.
    Wagner, T. T.
    Hundemer, H. -P.
    Karow, A.
    Schimmelmann, B. G.
    [J]. PHARMACOPSYCHIATRY, 2008, 41 (05) : 182 - 189
  • [40] Improvement of comorbid depression with olanzapine versus ziprasidone treatment in patients with schizophrenia or schizoaffective disorder
    Kinon, B
    Lipkovich, I
    Edwards, S
    Hill, A
    Ahl, J
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 163 - 163
12345